These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
125 related articles for article (PubMed ID: 26853532)
1. How to convey a diagnosis of skin cancer: patient preferences. Cooke N; Colver GB Br J Dermatol; 2016 Aug; 175(2):398-400. PubMed ID: 26853532 [No Abstract] [Full Text] [Related]
2. Hearing the bad news of a cancer diagnosis: the Australian melanoma patient's perspective. Schofield PE; Beeney LJ; Thompson JF; Butow PN; Tattersall MH; Dunn SM Ann Oncol; 2001 Mar; 12(3):365-71. PubMed ID: 11332150 [TBL] [Abstract][Full Text] [Related]
3. [How to announce the diagnosis for melanoma?]. Charles C; Rouby P; Robert C Rev Prat; 2014 Jan; 64(1):55-6, 59-60. PubMed ID: 24649547 [TBL] [Abstract][Full Text] [Related]
4. [Telephone information about malignant melanoma is common. More patients receive information about their diagnosis at their second visit]. Brandberg Y; Bolund C; Ringborg U; Sjödén PO Lakartidningen; 1995 Apr; 92(16):1705-7. PubMed ID: 7723488 [No Abstract] [Full Text] [Related]
5. Psychological responses of patients receiving a diagnosis of cancer. Schofield PE; Butow PN; Thompson JF; Tattersall MH; Beeney LJ; Dunn SM Ann Oncol; 2003 Jan; 14(1):48-56. PubMed ID: 12488292 [TBL] [Abstract][Full Text] [Related]
6. Talking with patients suffering from malignant melanoma. Milton GW Ann N Y Acad Sci; 1997 Feb; 809():330-5. PubMed ID: 9103584 [No Abstract] [Full Text] [Related]
7. [The announcement of bad news in dermatology]. Misery L; Legoupil D; Schollhammer M; Brenaut E; Abasq C; Roguedas-Contios AM; Chastaing M Ann Dermatol Venereol; 2014 Nov; 141(11):729-35. PubMed ID: 25442480 [No Abstract] [Full Text] [Related]
8. Patient satisfaction with receiving skin cancer diagnosis by letter: comparison with face-to-face consultation. Karri V; Bragg TW; Jones A; Soldin M; Misch K J Plast Reconstr Aesthet Surg; 2009 Aug; 62(8):1059-62. PubMed ID: 18485851 [TBL] [Abstract][Full Text] [Related]
10. Preferences regarding disclosure of prognosis and end-of-life care: A survey of cancer patients with advanced disease in a lower-middle-income country. Zafar W; Hafeez H; Jamshed A; Shah MA; Quader A; Yusuf MA Palliat Med; 2016 Jul; 30(7):661-73. PubMed ID: 26769733 [TBL] [Abstract][Full Text] [Related]
11. Patients are happy to be informed of their final non-melanoma skin cancer results by post. Thomson P; Palamaras I; Hill V; Robles W; Stevens H Dermatol Online J; 2010 Jan; 16(1):5. PubMed ID: 20137747 [TBL] [Abstract][Full Text] [Related]
12. Psychosocial distress and desire for support among inpatients with skin cancer. Buchhold B; Arnold A; Lutze S; Jülich A; Winkler M; Bahlmann J; Eggert C; Jünger M; Hannich HJ J Dtsch Dermatol Ges; 2017 Aug; 15(8):791-799. PubMed ID: 28763595 [TBL] [Abstract][Full Text] [Related]
13. Race as a predictor of patient preferences for biopsy result communication. Thareja S; Fink M; Chen KH; Liu Y; Chen SC; Stoff BK J Am Acad Dermatol; 2018 Jun; 78(6):1223-1225.e1. PubMed ID: 29223577 [No Abstract] [Full Text] [Related]
14. [For the benefit of the patient: the sentinel node excision]. Satzger I; Klein M; Löser C; Möhrle M; Reske S; Kapp A; Gutzmer R J Dtsch Dermatol Ges; 2011 Nov; 9(11):922-6. PubMed ID: 22026360 [No Abstract] [Full Text] [Related]
15. Patients' preferences for biopsy result notification in an era of electronic messaging methods. Choudhry A; Hong J; Chong K; Jiang B; Hartman R; Chu E; Nelson K; Wei ML; Nguyen T JAMA Dermatol; 2015 May; 151(5):513-21. PubMed ID: 25831475 [TBL] [Abstract][Full Text] [Related]
16. [Skin cancer prevention in the family]. Hautarzt; 2006 Oct; 57(10):851. PubMed ID: 17186589 [No Abstract] [Full Text] [Related]
17. Patient preferences for the delivery of bad news - the experience of a UK Cancer Centre. Brown VA; Parker PA; Furber L; Thomas AL Eur J Cancer Care (Engl); 2011 Jan; 20(1):56-61. PubMed ID: 20148936 [TBL] [Abstract][Full Text] [Related]
18. How do prospective parents prefer to receive information about prenatal screening and diagnostic testing? Willis AM; Smith SK; Meiser B; Muller C; Lewis S; Halliday J Prenat Diagn; 2015 Jan; 35(1):100-2. PubMed ID: 25196282 [No Abstract] [Full Text] [Related]
19. The unsolicited ominous diagnosis: legal, moral, and ethical considerations. Grant-Kels JM; Anderson JK; Kels BD J Am Acad Dermatol; 2012 Jun; 66(6):985-7. PubMed ID: 22583709 [No Abstract] [Full Text] [Related]
20. Skin cancer risk discussions in melanoma-affected families. Hay J; Ostroff J; Martin A; Serle N; Soma S; Mujumdar U; Berwick M J Cancer Educ; 2005; 20(4):240-6. PubMed ID: 16497137 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]